Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 2/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 6/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.36 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9924076 | 0.91 | CHRM1 (0.41) | CHRM1MCHR1DRD2CYP2C9MAPK14 | |
| SCHEMBL9924156 | 0.89 | CHRM1 (0.45) | CHRM1MCHR1DRD2CYP2C9MAPK14 | |
| SCHEMBL9924432 | 0.86 | CHRM1 (0.43) | CHRM1MCHR1CYP2C9MAPK14TAS1R3 | |
| SCHEMBL17206716 | 0.86 | CHRM1 (0.43) | CHRM1MCHR1CYP2C9MAPK14TAS1R3 | |
| SCHEMBL9924158 | 0.86 | CHRM1 (0.42) | CHRM1MCHR1DRD2CYP2C9MAPK14 | |
| SCHEMBL17206707 | 0.85 | TAS1R3 (0.43) | CHRM1MCHR1CYP2C9MAPK14TAS1R3 | |
| SCHEMBL17206712 | 0.85 | CHRM1 (0.43) | CHRM1MCHR1TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL17206703 | 0.83 | CHRM1 (0.41) | CHRM1MCHR1DRD2CYP2C9MAPK14 | |
| SCHEMBL9923856 | 0.82 | CHRM1 (0.42) | CHRM1MCHR1CYP2C9MAPK14ALDH1A1 | |
| SCHEMBL9924276 | 0.81 | EPHX2 (0.42) | CHRM1MCHR1CYP2C9MAPK14EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9169199-B2 | Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof | LYCERA CORPORATION (US) | 2015-10-27 | — | — | US | disclosed |
| WO-2012078867-A2 | CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF | LYCERA CORPORATION (US) | 2012-06-14 | — | — | WO | disclosed |